Abcam plc
DelistedCIK 1492074fmd_09ZD6B43VM83TPZWCDE2NCZMAVManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jul 01, 2018 to Dec 31, 2022, 6 periods
| Line item | FY2021 | FY2022 |
|---|---|---|
| Total revenues | 315 | 362 |
| Cost of revenue | 91 | 91 |
| Gross profit | 225 | 271 |
| Research and development | 28 | 56 |
| Selling, general and administrative | 190 | 225 |
| Operating income | 7 | (10) |
| Interest expense | 3 | 6 |
| Income before taxes | 5 | (16) |
| Income tax expense | 0 | (7) |
| Net income from continuing operations | 4 | (9) |
| Net income | 4 | (9) |